Chemical Compound
Candesartan Cilexetil; 2-Ethoxy-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester; 1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate; 2-Ethoxy-1-[(2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl)methyl]-7-benzimidazolecarboxylic acid 1-(cyclohexyloxycarbonyloxy)ethyl ester; Atacand; Blopress; Candesartan cilexetil; TCV 116; TCY 116; (+/-)-2-Ethoxy-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester; (+/-)-1-Hydroxyethyl 2-ethoxy-1-[p-(o-1H-tetrazol-5-ylphenyl)l]-7-benzimidazolecarboxylate, cyclohexyl carbonate (ester)
CAS Registry Number
145040-37-5
Primary record
Candesartan Cilexetil; 2-Ethoxy-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester; 1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate; 2-Ethoxy-1-[(2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl)methyl]-7-benzimidazolecarboxylic acid 1-(cyclohexyloxycarbonyloxy)ethyl ester; Atacand; Blopress; Candesartan cilexetil; TCV 116; TCY 116; (+/-)-2-Ethoxy-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester; (+/-)-1-Hydroxyethyl 2-ethoxy-1-[p-(o-1H-tetrazol-5-ylphenyl)l]-7-benzimidazolecarboxylate, cyclohexyl carbonate (ester)
- 库存
- 900 克
- 纯度
- 99.8 %
- CAS
- 145040-37-5
化合物标识与属性
- CAS
- 145040-37-5
- PubChem CID
- 2540
- SMILES
- CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)OC(C)OC(=O)OC6CCCCC6
- Canonical SMILES
- CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1
名称与同义词
- Candesartan cilexetil
- Atacand
- 145040-37-5
- Blopress
- Amias
- candesartancilexetil
- Parapres
- Kenzen
- Ratacand
- TCV-116
- candesartan
- Racanda
- candesartan cilexitil
- CANDESARTAN CILEXTIL
- Candesartan hexetil
- Atacand (TN)
- Candesartan cilexetil [USAN]
- Candesartan cilexetil?
- ATACAND HCT
- Spectrum_001707
- Candesartan Cilexetil-d11
- TCV 116
- RefChem:56666
- DTXSID5020239
- AC1L1DWQ
- Spectrum2_000485
- Spectrum3_000996
- Spectrum4_001124
- Spectrum5_001462
- Candesartan cilexetil CRS
- CHEMBL1014
- MFCD00871371
- Candesartan Celexetil Ester
- DTXCID50239
- UNII-R85M2X0D68
- GHOSNRCGJFBJIB-UHFFFAOYSA-N
- C33H34N6O6
- R85M2X0D68
- SCHEMBL40831
- BSPBio_002691
- KBioGR_001607
- KBioSS_002187
- MLS004774127
- PBCMNDESARTAN CILEXETIL
- Candesartan cilexetil , 97%
- NSC-758697
- SCHEMBL612936
- SPECTRUM1504261
- SPBio_000349
- CHEBI:3348
- GTPL8352
- orb1305541
- Candesartan cilexetil (Atacand)
- Candesartan N-Cilexetil Impurity
- Candesartan Cilexetil (Standard)
- ERK5-3L13
- KBio2_002187
- KBio2_004755
- KBio2_007323
- KBio3_001911
- KS-00000IVU
- CID2540
- EBD4212
- TCY 116
- GLXC-07961
- HMS1922J09
- HMS2093E20
- HMS3651I08
- HMS5080P17
- Pharmakon1600-01504261
- Candesartan cilexetil (JP18/USP)
- CANDESARTAN CILEXETIL [JAN]
- ALBB-038627
- BCP22050
- CID:2540
- MSK10658
- Tox21_302202
- AC-204
- BDBM50318907
- CANDESARTAN CILEXETIL [VANDF]
- CCG-39530
- EBC-11266
- HY-17505R
- NP3201
- NSC758697
- s2037
- STL451065
- CANDESARTAN CILEXETIL [MART.]
- AKOS015894954
- AKOS015920180
- C33-H34-N6-O6
- CANDESARTAN CILEXETIL [USP-RS]
- CANDESARTAN CILEXETIL [WHO-DD]
- AB07617
- ACN-037206
- AM90293
- AN-7256
- BCP9000480
- CCG-222334
- CS-2893
- CS-O-00538
- DB00796
- DS-1302
- EBC-656142
- FC19661
- KS-1147
- NSC 758697
- VA10473
- Candesartan cilexetil, >=98% (HPLC)
- NCGC00095123-01
- NCGC00095123-02
- NCGC00095123-03
- NCGC00095123-05
- NCGC00095123-10
- NCGC00095123-16
- NCGC00255218-01
- AK-75900
- BC164274
- BC209195
- BR-75900
- Candesartan cilexetil - Bio-X trade mark
- Candesartan cilexetil CRS (Y0001388)
- HY-17505
- LS-32741
- SC-12740
- SID:53790860
- SMR003500784
- SY051248
- CANDESARTAN CILEXETIL [ORANGE BOOK]
- SBI-0206767.P001
- AB0012012
- AB2000442
- CANDESARTAN CILEXETIL [EP MONOGRAPH]
- TL8000995
- 4CH-009595
- C-265
- C2635
- CANDESARTAN CILEXETIL [USP MONOGRAPH]
- CAS-145040-37-5
- NS00006138
- ST24030238
- SW220041-1
- Candesartan 1-(((cyclohexyloxy)carbonyl)oxy)ethyl ester
- J1.640.921I
- A-2005
- C07709
- D00626
- EN300-118698
- J10436
- AB01274805-01
- AB01274805_02
- AB01274805_03
- Candesartan cilexetil for peak identification CRS
- Candesartan cilexetil for system suitability CRS
- 040C375
- A848411
- C077793
- H212/91
- L006257
- SR-05000001976
- 1-(((Cyclohexyloxy)carbonyl)oxy)ethyl 1-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate
- 1-cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate
- Atacand;Amias;Blopress;Ratacand;TCV 116;TCY 116
- I06-0090
- SR-05000001976-1
- BRD-A65671304-001-02-6
- BRD-A65671304-001-03-4
- BRD-A65671304-001-07-5
- BRD-A65671304-001-08-3
- Q27075664
- 1H-Benzimidazolium, 7-carboxy-1-(2-((cyclohexylcarbonyl)oxy)ethyl)-2-ethoxy-1-(2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)-, hydroxide, inner salt, (+-)-
- Candesartan 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester
- Candesartan cilexetil, 98%, an ATR antagonist - 1G 1g
- Z1515383338
- 1-(cyclohexoxycarbonyloxy)ethyl 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate
- 1-(cyclohexylocarbonyloxy)ethyl-2-ethoxy-1-(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)-1H-benzimidazole-7-carboxylate
- 1-(cyclohexyloxycarbonyloxy)ethyl 1-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate
- 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-[[2'-(1h-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1h-benzimidazole-7-carboxylate
- 1261393-19-4
- Candesartan Cilexetil for System Suitability CRS (Y0001389)
- CANDESARTAN 1-(((CYCLOHEXYLOXY)CARBONYL)OXY)ETHYL ESTER [MI]
- (+-)-1-Hydroxyethyl 2-ethoxy-1-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylate, cyclohexyl carbonate (ester)
- 1-(((cyclohexyloxy)carbonyl)oxy)ethyl 1-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate
- 1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-(ethyloxy)-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylate
- 1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-ethoxy-1-{[2'-(1H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}-1H-1,3-benzodiazole-7-carboxylate
- 1H-Benzimidazole-7-carboxylic acid, 2-ethoxy-1-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-, 1-(((cyclohexyloxy)carbonyl)oxy)ethyl ester, (+-)-
- 2-ETHOXY-1-[[2'-(2H-TETRAZOL-5-YL)[1,1'-BIPHENYL]-4-YL]METHYL]-1H-BENZIMIDAZOLE-7-CARBOXYLIC ACID 1-[[(CYCLOHEXYLOXY)CARBONYL]OXY]ETHYL ESTER
- 2-Ethoxy-3-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3H-benzoimidazole-4-carboxylic acid 1-cyclohexyloxycarbonyloxy-ethyl ester
- Candesartan cilexetil, European Pharmacopoeia (EP) Reference Standard
- Candesartan cilexetil, United States Pharmacopeia (USP) Reference Standard
- Candesartan cilexetil for peak identification, European Pharmacopoeia (EP) Reference Standard
- Candesartan cilexetil for system suitability, European Pharmacopoeia (EP) Reference Standard
- Candesartan Cilexetil, Pharmaceutical Secondary Standard; Certified Reference Material
- (+/-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[2'-(1H-tetrazol-5-yl) biphenyl-4-yl]methylbenzimidazole-7-carboxylate
- (+/-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methylbenzimidazole-7-carboxylate
- (+/-)-1-HYDROXYETHYL 2-ETHOXY-1-(P-(O-1H-TETRAZOL-5-YLPHENYL)BENZYL)-7-BENZIMIDAZOLECARBOXYLATE, CYCLOHEXYL CARBONATE (ESTER)
- (1RS)-1-(Cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1H-benzimidazole-7-carboxylate
- 1-(((Cyclohexyloxy)carbonyl)oxy)ethyl 1-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-ethox
- 1-(((Cyclohexyloxy)carbonyl)oxy)ethyl1-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate
- 1-(1,2,2,3,3,4,4,5,5,6,6-undecadeuteriocyclohexyl)oxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate
- 1-(Cyclohexyloxycarbonyloxy)ethyl-2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazol-7-carboxylate
- 1-[[2 -(1H-Tetrazole-5-yl)-1,1 -biphenyl-4-yl]methyl]-2-ethoxy-1H-benzoimidazole-7-carboxylic acid 1-[(cyclohexyloxycarbonyl)oxy]ethyl ester
- 1-[2 -(1H-Tetrazole-5-yl)-4-biphenylylmethyl]-2-ethoxy-1H-benzoimidazole-7-carboxylic acid 1-(cyclohexyloxycarbonyloxy)ethyl ester
- 1-[2 -(1H-Tetrazole-5-yl)-4-biphenylylmethyl]-2-ethoxy-1H-benzoimidazole-7-carboxylic acid 1-[(cyclohexyloxy)carbonyloxy]ethyl ester
- 1-{[(Cyclohexyloxy)carbonyl]oxy}ethyl 2-ethoxy-1-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-1H-1,3-benzimidazole-7-carboxylate
- 1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylate
- 1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-ethoxy-1-{[2'-(2H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}-1H-1,3-benzodiazole-7-carboxylate
- 1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-ethoxy-3-({4-[2-(1H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1,3-benzodiazole-4-carboxylate
- 1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-ethoxy-3-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1,3-benzodiazole-4-carboxylate
- 1-cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(2h-tetrazol-5-yl)phenyl]phenyl] methyl]benzimidazole-4-carboxylate
- 1-cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate.
- 139481-59-7
- 1H-Benzimidazole-7-carboxylic acid, 2-ethoxy-1-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-, 1-(((cyclohexyloxy)carbonyl)oxy)ethyl ester, ( -)-
- 1H-BENZIMIDAZOLE-7-CARBOXYLIC ACID, 2-ETHOXY-1-((2'-(1H-TETRAZOL-5-YL)(1,1'-BIPHENYL)-4-YL)METHYL)-, 1-(((CYCLOHEXYLOXY)CARBONYL)OXY)ETHYL ESTER, (+/-)-
- 1H-Benzimidazole-7-carboxylic acid,2-ethoxy-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-,1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester
- 2-Ethoxy-1-[(2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl)methyl]-7-benzimidazolecarboxylic acid 1-(cyclohexyloxycarbonyloxy)ethyl ester
- 2-Ethoxy-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid 1-[[(cyclohexyloxy)carbonyl]oxy]et hyl ester
- 2-Ethoxy-1-[2 -(1H-tetrazole-5-yl)-4-biphenylylmethyl]-1H-benzimidazole-7-carboxylic acid 1-(cyclohexyloxycarbonyloxy)ethyl ester
- 2-Ethoxy-3-[2''-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3H-benzoimidazole-4-carboxylic acid 1-cyclohexyloxycarbonyloxy-ethyl ester
- 2-Ethoxy-3-[2''-(2H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3H-benzoimidazole-4-carboxylic acid 1-cyclohexyloxycarbonyloxy-ethyl ester
- 2-ethoxy-3-[2'-(1h-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3h-benzoimidazole-4-carboxylic acid 1-cyclohe
- Candesartan Cilexetil; 2-Ethoxy-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester; 1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate; 2-Ethoxy-1-[(2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl)methyl]-7-benzimidazolecarboxylic acid 1-(cyclohexyloxycarbonyloxy)ethyl ester; Atacand; Blopress; Candesartan cilexetil; TCV 116; TCY 116; (+/-)-2-Ethoxy-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester; (+/-)-1-Hydroxyethyl 2-ethoxy-1-[p-(o-1H-tetrazol-5-ylphenyl)l]-7-benzimidazolecarboxylate, cyclohexyl carbonate (ester)